Cutler Group LP Karuna Therapeutics, Inc. Call Options Transaction History

Cutler Group LP

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Jan 18, 2024	BUY	$161.01 - $317.85 $112,707 - $222,495	700 New	700 $63,000
Q3 2022 Oct 25, 2022	BUY	$123.79 - $277.42 $185,685 - $416,130	1,500 New	1,500 $1,000
Q3 2021 Oct 26, 2021	SELL	$101.2 - $125.87 $70,840 - $88,109	-700 Closed	0 $0
Q2 2021 Jul 19, 2021	BUY	$107.45 - $135.95 $10,745 - $13,594	100 Added 16.67%	700 $1,000
Q2 2020 Jul 22, 2020	BUY	$62.14 - $117.21 $24,856 - $46,884	400 Added 200.0%	600 $9,000
Q1 2020 May 07, 2020	BUY	$60.41 - $115.92 $12,082 - $23,184	200 New	200 $0

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.